Studying the use of CRISPR on human liver-on-a-chip platform
22 October, 2018Two US researchers are combining their expertise in CRISPR technology and human microphysiological systems to assess the safety and efficacy of genome editing.
Same-sex mice reproduce via gene editing
15 October, 2018Researchers from the Chinese Academy of Sciences have produced healthy mice with two mothers that went on to have normal offspring of their own.
How could gene editing serve NZ's primary industries?
05 October, 2018Removing allergens from milk, making mānuka disease resistant and preventing wilding pines are some potential future uses of gene editing in New Zealand.
Liposoma clodronate liposomes
04 October, 2018Liposoma's clodronate liposomes are artificial spheres consisting of concentric phospholipid bilayers encapsulating an aqueous PBS (phosphate buffered saline) solution containing clodronate.
Collaboration to evaluate immunotherapy and antibody combination
28 September, 2018Biotechnology company Immutep has entered into a clinical trial collaboration and supply agreement with Merck and Pfizer.
Antimalarial drug boosted with chemo medicines
24 September, 2018Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug, in a breakthrough that may overcome antimalarial drug resistance.
Medlab granted a licence to export cannabis
12 September, 2018The licence relates to Medlab Clinical's two cannabis-based medicines — NanaBis and NanaBidial.
STEM superstar on the juggle, the struggle and the joy
06 September, 2018 by Jess Melbourne-ThomasMarine ecologist and ecosystem modeller Jess Melbourne-Thomas is one of two Tasmanians who were named as Science and Technology Australia's Superstars of STEM* in 2017/18. Here she reflects on her passion for marine science and recommends people to apply to the program.
Promising new drug candidate designed to lower cholesterol
06 September, 2018The drug candidate NYX-330 is designed to lower cholesterol levels by inhibiting the action of a protein known as PCSK9.
Injectable migraine treatment approved in Australia
04 September, 2018Aimovig — the first in a new class of long-acting, injectable medications for the prevention of migraine in adults — has been approved for use in Australia.
Specialised Therapeutics unveils new Australian headquarters
27 August, 2018Pharmaceutical company Specialised Therapeutics Australia celebrated its 10th anniversary with a business plan to drive healthcare innovation over the next decade.
Insulin resistance drug instead tackles obesity
24 August, 2018A newly developed drug has been found to prevent mice from depositing and storing fat by increasing their ability to burn fat in skeletal muscle.
Agreement to develop a new class of antibiotics
20 August, 2018WA's Telethon Kids Institute and Boulos & Cooper Pharmaceuticals have signed an agreement to develop what could be the first new class of antibiotics in decades.
Biotech start-up to treat autoimmune diseases with hookworms
17 August, 2018Experimental infection of human subjects with hookworms can protect against the onset of autoimmune diseases, according to newly launched biotech Paragen Bio.
Patient enrolment for Alzheimer's trial close to completion
15 August, 2018Actinogen Medical has announced 75% enrolment in its Phase II clinical trial of Xanamem, its drug candidate for the treatment of mild Alzheimer's disease.
